Thomas Dietz - Insider Trading & Ownership

Entity
Individual
Location
C/O Transcept Pharmaceutical, Inc., 1003 W. Cutting Blvd, Ste 110, Pt. Richmond, CA
Summary
The estimated net worth of Thomas Dietz is at least $21.1K dollars as of January 31, 2024. Thomas Dietz is the Director of Eiger BioPharmaceuticals, Inc. and owns shares of Eiger BioPharmaceuticals, Inc. (EIGRQ) stock worth about $21.1K.
All Insider Reports
All Insider Reports

Ownership of Thomas Dietz

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EIGRQ Eiger BioPharmaceuticals, Inc. Director $21.1K Mar 1, 2023
LPTX LEAP THERAPEUTICS, INC. Director Jan 29, 2024
PRTK Paratek Pharmaceuticals, Inc. Director Sep 21, 2023

Insider Transactions Reported by Thomas Dietz:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.